Mysimba 8 mg / 90 mg prolonged-release tablets
- Licence status
- Active substances
- Naltrexone hydrochloride, Bupropion hydrochloride
- Dosage Form
- Prolonged-release tablet
- Licence number
- EU/1/14/988/001-002
- Licence holder
- Orexigen Therapeutics Ireland Limited
Product documents
Licence information
- ATC code
- A08AA Centrally acting antiobesity products, A08AA62 Bupropion and Naltrexone
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued